Hiramatsu Rikako, Ubara Yoshifumi, Sawa Naoki, Hasegawa Eiko, Kawada Masahiro, Imafuku Aya, Sumida Keiichi, Hoshino Junichi, Takaichi Kenmei
Nephrology Center, Toranomon Hospital, Japan.
Intern Med. 2016;55(20):3013-3019. doi: 10.2169/internalmedicine.55.6806. Epub 2016 Oct 15.
We performed a bone histomorphometric analysis in two patients demonstrating Fanconi syndrome with hypophosphatemia, adefovir-related bone disease and chronic hepatitis B infection. Both patients had osteomalacia, but showed two different histological patterns. The osteoid volume of the patient without risedronate increased with [(osteoid volume/ bone volume)×100=18.6%]. However, the osteoid volume of the patient receiving risedronate without vitamin D analogue showed a greater increase of 53.8%. In both patients bone pain and hypophosphatemia subsided soon after the discontinuation of adefovir and the administration of phosphate derivative. These findings show that bisphosphonate may worsen this disease when this drug is administered without a vitamin D analogue.
我们对两名患有范科尼综合征伴低磷血症、阿德福韦相关骨病和慢性乙型肝炎感染的患者进行了骨组织形态计量学分析。两名患者均患有骨软化症,但表现出两种不同的组织学模式。未使用利塞膦酸盐的患者类骨质体积增加,[(类骨质体积/骨体积)×100 = 18.6%]。然而,接受利塞膦酸盐但未使用维生素D类似物的患者类骨质体积增加幅度更大,为53.8%。在两名患者中,停用阿德福韦并给予磷酸盐衍生物后,骨痛和低磷血症很快缓解。这些发现表明,在未使用维生素D类似物的情况下使用双膦酸盐可能会使这种疾病恶化。